Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/12/1998WO1998009632A1 Methods and compositions for treating preterm labor
03/12/1998WO1998009631A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009629A1 Crystalline pharmaceutical product
03/12/1998WO1998009628A1 Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
03/12/1998WO1998009627A1 Compositions and methods for treating erectile impotence
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS
03/12/1998WO1998009624A1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same
03/12/1998WO1998009623A2 Use of cholinergic drugs
03/12/1998WO1998009621A1 Fatty acid treatment
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009619A1 Novel methods
03/12/1998WO1998009618A2 Graft survival prolongation with porphyrins
03/12/1998WO1998009616A1 Solid foamed active substance preparations
03/12/1998WO1998009603A2 Compositions including r-nsaids and therapeutic and prophylactic methods employing said compositions
03/12/1998WO1998009599A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009526A1 Antioxidant derived from lentil and its preparation and uses
03/12/1998WO1998009524A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
03/12/1998WO1998009523A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/12/1998WO1998009520A1 Antimicrobial compositions
03/12/1998WO1998009519A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998002169A3 Novel formulations for the administration of fluoxetine
03/12/1998WO1998002147A3 Transdermal therapeutic systems
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998WO1997046262A3 Membrane incorporation of texaphyrins
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes
03/12/1998DE19636882A1 New aminated hydroxy-alkynyl-xanthine derivatives
03/12/1998DE19636769A1 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
03/12/1998DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives
03/12/1998DE19636364A1 Medicament for neutralising blood or other body fluids
03/12/1998DE19636150A1 N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung N-substituted indole-3-glyoxylamides with anti-asthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
03/12/1998DE19636046A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten New carboxylic acid derivatives, their preparation and use as a mixed ET¶A¶ / ET¶B¶ receptor antagonists
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2592537A1 Nitric ester derivatives in the treatment of inflammatory diseases
03/12/1998CA2591612A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2279651A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2265526A1 Fatty acid treatment
03/12/1998CA2265504A1 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998CA2264943A1 Novel methods
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264806A1 Novel .beta.-lactam compounds and process for preparing the same
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264775A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264725A1 Methods of making hiv-protease inhibitors and intermediates for making them
03/12/1998CA2264654A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998CA2264607A1 Crystalline pharmaceutical product
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264286A1 Antimicrobial compositions
03/12/1998CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2264052A1 25-methylene and 24,25-epoxy marcfortines and paraherquamides
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2263250A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/12/1998CA2263198A1 Novel acetamide derivatives and protease inhibitors
03/12/1998CA2261655A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998CA2234886A1 Graft survival prolongation with porphyrins
03/12/1998CA2215015A1 Treating prostate hypertrophy and prostate cancer
03/11/1998EP0827964A2 S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleo-side complexes as potent inhibitors of HIV-replication
03/11/1998EP0827959A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/11/1998EP0827749A2 Peritoneal dialysis solution
03/11/1998EP0827748A2 Peritoneal dialysis solution
03/11/1998EP0827747A1 Analgetic agent
03/11/1998EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists
03/11/1998EP0827745A1 Anti-tumour compositions containing taxan derivatives
03/11/1998EP0827744A2 Use of amino acids for the manufacture of a medicament for inhibiting or activating glutamic acid in the brain
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827741A2 Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as an active ingredient
03/11/1998EP0827698A2 Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827545A2 Retroviral vectors
03/11/1998EP0827514A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
03/11/1998EP0827507A1 Protease inhibiting succinic acid derivatives
03/11/1998EP0827505A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
03/11/1998EP0827503A1 Pyrrolidinyl methyl indole salt
03/11/1998EP0827500A1 (2-morpholinylmethyl)benzamide derivatives
03/11/1998EP0827498A1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
03/11/1998EP0827405A2 Use of dihydrotestosterone compounds for treating male sexual dysfunction
03/11/1998EP0827404A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
03/11/1998EP0827403A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
03/11/1998EP0827402A2 Compositions containing fatty acids for improving digestion and absorption in the small intestine
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0827399A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
03/11/1998EP0827397A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0827395A1 Topically applicable agents for treating and preventing alopecia
03/11/1998EP0827393A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
03/11/1998EP0827392A1 Cosmetic or dermatological preparations containing phytic acid
03/11/1998EP0786997A4 Muscarine antagonists
03/11/1998EP0785933B1 Indole derivatives as 5ht1-like agonists
1 ... 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 6698 6699 6700 ... 7860